Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed Feb 21, 2024 · 10-K · 52 days after period end · 0001493152-24-007432
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | — | $0.00 |
| Net Income | -$1.55M | $893.46K | -$177.74K | -$453.71K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Feb 21, 2024 · 52 d after period end
